Notch is out — your watchlist beside the MacBook notch, synced with this account.
Learn more ↗We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
OliPass is a biotech company specializing in the development of RNA therapeutics. Leveraging its proprietary OliPass PNA platform technology, the company is discovering new drug candidates for various diseases such as pain, hyperlipidemia, and non-alcoholic steatohepatitis (NASH). Its primary business areas are the research, development, and manufacturing of innovative new drugs.
올리패스는 RNA 치료제 개발을 전문으로 하는 바이오 기업입니다. 자체 개발한 OliPass PNA 플랫폼 기술을 활용하여 통증, 고지혈증, 비알코올성 지방간염(NASH) 등 다양한 질환에 대한 신약 후보물질을 발굴하고 있습니다. 주요 사업 영역은 혁신 신약 연구 개발 및 제조입니다.
